Biological printers can save humanity from bacterial infections

The US Centers for Disease Control and Prevention has purchased HPD300e biological printers to combat the harmful effects of bacterial infections on the human body.

For hundreds of years, mankind has been struggling with countless bacteria that cause dangerous and, at times, incurable diseases. The invention of antibiotics significantly improved the situation in public health, however, over time, bacteria learned to adapt to the substances that destroy them, mutates and changes the structure of their molecules. As a result, specialists were forced to create new drugs. The rate of mutations over time has reached such a level that in laboratories they simply did not keep pace with newly emerging bacteria, epidemics swept humanity, and medicines were not yet created.

Bacteria that do not respond to conventional therapy have been given the name “superbugs”.

According to the results of research conducted in the United States, about two million people in the country each year become infected with superbugs. And these are just statistics, in fact there are much more such people.

With the help of biological printers, a bacterial field will be launched on which to experiment and conduct experiments. The principle of operation of a bioprinter is similar to the mechanism of action of a familiar apparatus; however, instead of ink, such a device uses a substrate consisting of patient cells. This basis, "printed" on the printer, allows you to try on her various combinations of drugs, determining the degree of their impact on the cells of a particular patient. In accordance with the results obtained, an effective treatment regimen is prescribed.

The authors of the project are counting on the fastest possible introduction of biological printers in laboratories and medical institutions in the United States. This will significantly improve the quality of treatment, and thus save thousands of lives.